HL Financial Services LLC Boosts Position in Humana Inc. (NYSE:HUM)
HL Financial Services LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 0.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,963 shares of the insurance provider’s stock after buying an additional 68 shares during the period. HL Financial Services LLC’s holdings in Humana were worth $1,916,000 as of its most recent filing with the SEC.
Other large investors also recently bought and sold shares of the company. Independent Portfolio Consultants Inc. increased its stake in Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares during the last quarter. Guardian Life Insurance Co. of America increased its stake in Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after buying an additional 4 shares during the last quarter. Point72 Asia Hong Kong Ltd bought a new stake in Humana during the first quarter worth about $128,000. Westbourne Investment Advisors Inc. bought a new stake in Humana during the second quarter worth about $205,000. Finally, Hengehold Capital Management LLC bought a new stake in Humana during the second quarter worth about $209,000. Institutional investors own 99.66% of the company’s stock.
Shares of Humana Inc. (NYSE HUM) opened at 254.96 on Thursday. The stock has a market capitalization of $36.85 billion, a PE ratio of 20.97 and a beta of 0.91. The firm has a 50-day moving average of $238.81 and a 200 day moving average of $222.35. Humana Inc. has a 1-year low of $163.50 and a 1-year high of $255.10.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The business had revenue of $13.53 billion during the quarter, compared to the consensus estimate of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same quarter in the prior year, the firm earned $2.30 EPS. On average, equities analysts anticipate that Humana Inc. will post $11.45 earnings per share for the current fiscal year.
A number of research firms have recently issued reports on HUM. UBS AG reiterated a “neutral” rating and set a $237.00 price target (up from $205.00) on shares of Humana in a research report on Wednesday, June 28th. Cantor Fitzgerald reiterated a “neutral” rating and set a $223.00 price target (up from $200.00) on shares of Humana in a research report on Thursday, August 3rd. Jefferies Group LLC reiterated a “hold” rating and set a $257.00 price target on shares of Humana in a research report on Friday, August 4th. Zacks Investment Research downgraded shares of Humana from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Finally, BidaskClub downgraded shares of Humana from a “hold” rating to a “sell” rating in a research report on Monday, July 31st. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the stock. Humana has a consensus rating of “Hold” and a consensus target price of $243.65.
In related news, VP Heidi S. Margulis sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $231.96, for a total value of $347,940.00. Following the completion of the sale, the vice president now owns 8,150 shares in the company, valued at approximately $1,890,474. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Brian P. Leclaire sold 4,971 shares of the company’s stock in a transaction that occurred on Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the completion of the sale, the senior vice president now owns 14,258 shares of the company’s stock, valued at approximately $3,421,920. The disclosure for this sale can be found here. 0.80% of the stock is currently owned by corporate insiders.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.